Internal Medicine Alert – June 30, 2003
June 30, 2003
View Issues
-
Effect of Lipid-Lowering Therapies on Stroke Prevention
Lipid-lowering therapy reduces stroke incidence in coronary patients, especially when total cholesterol level is lowered to less than 232 mg/dL (6.0 mmol/L), which explains the best results being obtained with statins. -
The Case of the Contaminated Keyboard: Does It Compute?
Computer keyboards may serve as reservoirs for serious nosocomial pathogens. -
Clinical Outcomes and Health Care Costs for Physician-Diagnosed Peptic Ulcer Disease
Even in physician-diagnosed peptic ulcer disease, test-and-treat strategy for H pylori did not reduce costs, and use of acid-reducing medications remained very high. -
Oregon’s Assisted Suicide Program
An update on Oregons assisted suicide program since it became legal in 1997. -
Iontophoresis for Tennis Elbow
Iontophoresis was more effective than placebo in relieving tennis elbow symptoms in the short term. -
Rapid Parkinsonism Follows 20% of Cirrhosis
Cirrhosis-related parkinsonism may represent a unique, consistent, and common subset of acquired hepatocerebral degeneration, whose features are permanent and entirely different from acute hepatic encephalopathy episodes. -
Pharmacology Update: Aripiprazole Tablets (Abilify — Bristol-Myers Squibb)
Aripiprazole is a new antipsychotic agent approved for the treatment of schizophrenia. This atypical agent is a quinolinone that has partial agonist activity at dopamine D2 receptors. The drug will be marketed as being better tolerated and safer than other atypical agents, as well as being dosed once a day. -
Clinical Briefs
Increase in Blood Glucose Concentration During Antihypertensive Treatment as a Predictor of Myocardial Infarction; Adverse Drug Events in Ambulatory Care; Prevention of Hip Fracture by External Hip Protectors